Recare, a health-tech company based in Berlin, has raised €37 million in a major funding round. This investment could change how European hospitals manage administrative work. With backing from a global assurance leader and strong financial partners, Recare is expanding its AI platform to tackle expensive and often overlooked problems like disconnected workflows and manual coordination. The new funding will help the company expand internationally and play a bigger role in hospital operations.
Where the Idea Took Shape
Maximilian Greschke and Charles Cote started Recare in Berlin in 2017 after noticing that hospitals were wasting time and money because their administrative systems were not connected. Tasks like discharge planning, referrals, and coordination with care providers were mostly done by phone, email, and paperwork. The founders wanted to create a platform that would connect these groups and automate information sharing, all without requiring hospitals to replace their current IT systems.
Recare set out to solve a major structural problem from the start. Instead of just digitizing individual tasks, the company wanted to manage whole workflows so that data, documents, and coordination could move smoothly between different organizations.
Inside Recare’s AI Engine
Recare is a software-as-a-service platform built to manage complex healthcare workflows. It is especially helpful for discharge management and for coordinating care after patients leave the hospital, where delays can mean longer stays and higher costs. The platform helps hospitals match patients with the right follow-up care providers and handles documentation and communication automatically.
Recare’s AI technology is key to turning unstructured medical data into useful, shareable information. It analyses documents, scanned forms, and free-text records, organizing them so they can be shared between different systems and organisations. Over time, the platform has grown to connect departments, facilities, and care networks, cutting down on manual work and easing administrative bottlenecks.
Also Read: Vimag Labs Raises $5 Million to Push Magnet-Free Motor Innovation
From National Adoption to System-Level Impact
Recare has grown significantly in Germany’s healthcare system. About two-thirds of German hospitals now use the platform, along with hundreds of rehabilitation clinics and more than 26,000 nursing and homecare providers. This broad use shows both the urgency of the problem and the trust Recare has earned in a highly regulated market.
Before this latest round, Recare had raised €3.2 million, which helped improve its product and grow its hospital network. The new €37 million investment is a turning point, taking the company from leading in Germany to expanding across Europe.
Capital, Control, and Strategic Backing
The growth round was led by DNV, the global assurance and risk-management company with operations spanning more DNV, a global assurance and risk-management company operating in over 100 countries, led the funding round. With this investment, DNV is now Recare’s largest shareholder, showing a shared focus on reliability, compliance, and long-term value. CIBC Innovation Banking also joined, along with existing investors, bringing more financial support and expertise. The deal includes a €7 million option, giving Recare extra flexibility as it grows. bone for healthcare operations, where security, compliance, and resilience are non-negotiable.
How the New Capital Will Be Deployed
Recare plans to channel the funding into advancing its AI agent capabilities, enabling deeper automation across Recare will use the funding to improve its AI agent, allowing for more automation in both administrative and clinical coordination tasks. By increasing what the AI can do on its own, the company hopes to save healthcare professionals even more time on paperwork and system tasks. additional European markets facing similar challenges, including staff shortages and fragmented care systems. The capital will support regulatory adaptation, local partnerships, and scaled deployments across new regions. Investment will also go into strengthening integrations, expanding the team, and supporting larger healthcare networks as adoption grows.
Why Recare Matters Right Now
European healthcare systems are under more pressure because of aging populations, more patients, and ongoing staff shortages. Europe could be short about one million doctors and nurses by the end of the decade. As a result, making operations more efficient is now a top priority. Recare has a unique role in this situation. Instead of competing with electronic health record providers, it works alongside them by focusing on execution and coordination. Its value is in helping existing systems work together more effectively, delivering quick, measurable efficiency gains without major changes.
Scaling the Blueprint for Smarter Hospitals
With €37 million in new funding, a strong lead investor, and a solid presence in Germany, Recare is entering its next phase as a major European health-tech company. By making AI-driven workflow management practical and scalable, Recare is becoming a key part of modern hospital operations. As hospitals look for ways to do more with less, Recare’s solution is likely to become even more important.
Also Read: PaleBlueDot AI Enters Unicorn Club as Neocloud Infrastructure Attracts Major Capital
